A system approach to improving guideline-directed therapy for cardio-renal-metabolic conditions: The “beyond diabetes” initiative

A system approach to improving guideline-directed therapy for cardio-renal-metabolic conditions: The “beyond diabetes” initiative

Objective: Despite demonstrating improvements in cardiovascular disease, kidney disease, and survival outcomes, guideline-directed antihyperglycemic medications such as sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like-peptide-1 receptor agonists (GLP1-RA), are underutilized. Many...

Full description

Bibliographic Details
Main Authors: Benjamin J. Hirsh, Jamie S. Hirsch, Hosam Hmoud, Spencer Weintraub, Agnes Cha, Martin Lesser, Xueqi Huang, Yan Yan Sally Xie, Rachel Nahrwold, John Joshua, Jennifer Scanlon, Thomas Galella, Varinder Singh, Eugenia Gianos
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:American Journal of Preventive Cardiology
Subjects:
Diabetes mellitus
Cardiovascular
Kidney
Outcomes
Systems-based
Initiative
Online Access:http://www.sciencedirect.com/science/article/pii/S2666667723001496

Internet

http://www.sciencedirect.com/science/article/pii/S2666667723001496

Similar Items